Pharmather Holdings Ltd PHRRF

Primary Symbol: C.PHRM

psychedelics

PharmaTher Holdings Ltd. is a Canada-based specialty pharmaceutical company. The Company develops and commercializes specialty pharmaceuticals exhibiting growing adoption and permitting delivery methods to enhance patient outcomes. Its lead product is KETARX (racemic ketamine) to fill the global unmet medical needs for anesthesia, sedation, pain, mental health, and neurological indications. The Company is also commercializing PharmaPatch (microneedle patch) with its partners to deliver psychedelics and drugs to treat infectious diseases.

CSE:PHRM - Post by User

Pharmather Holdings Ltd

<< Previous

Bullboard Posts

Next >>

Post by AwareInvestoron May 25, 2021 9:01am

131 Views

Post# 33258873

PharmaTher Files With FDA For Orphan Drug Designation In Use

PharmaTher Holdings this morning announced that it has filed with the US FDA for orphan drug designation as it works to further study the uses of ketamine. The latest filing pertains to the use of ketamine to treat Lou Gehrig’s disease, which is formally known as ALS, or amyotrophic lateral sclerosis.

https://thedeepdive.ca/pharmather-files-with-fda-for-orphan-drug-designation-in-use-of-ketamine-for-als/

<< Previous

Bullboard Posts

Next >>

Victoria Gold stock falls 82% after Yukon landslide halts production